Skip to main content
. 2020 Jul 29;223(6):1029–1039. doi: 10.1093/infdis/jiaa461

Table 1.

Cohort Summary: New Orleans Alcohol Use in HIV Study

Female (N = 108) Male (N = 251) Total (N = 359)
Variable Median or % IQR Median or % IQR Median or % IQR P  a
Demographic
 Age (years) 50 14 51 15 51 15 .707
 African American race, % 87 82 84 .357
 MSM, % 51 36 .662
Body mass index (kg/m2) 29 10 25 7 26 7 <.001
HIV
 Viral loadb (copies/mL) 0 59 0 39 0 45 .539
  <20, % 67 70 69 .759
  20–200, % 13 16 15 .653
  200–1 000 000, % 20 14 16 .281
 ART adherence > 90%, % 81 86 84 .400
 Hepatitis C coinfection, % 20 16 17 .386
Recent antibiotic usec, % 37 22 26 .004
Alcohol Use
 AUDIT (score) 4 11 7 11 6 11 .004
 Lifetime (g) 62 179 291 802 213 955 470 016 174 298 435 826 <.001
 30-day (g) 84 399 224 915 168 754 .004
 PEthd (ng/μL, N = 352) 14 89 49 240 34 179 <.001
Smoke-Tobacco Use
 Current, % 52 64 60 .038
 Pack-years in ever smokers 7 18 9 20 8 20 .039
Other Substance Use
 30-day (days) 0 9 0 6 0 6 .662
 Lifetime (years) 16 33 16 27 16 31 .557
CD8+ T Cells (cells/μL, N = 335)
 Total 683 404 759 422 730 429 .115
 Naive 157 128 139 127 144 129 .752
 Activated 28 22 27 34 28 30 .890
 Activated-senescent 13 17 13 21 13 20 .508
 Exhausted 4 8 3 8 3 8 .441
 TEMRA 71 63 62 69 64 65 .954
CD4+ T cells (cells/μL)
 Total 548 378 484 340 505 365 .456
 Naive 161 165 152 180 156 178 .635
 Activated 9 7 9 7 9 7 .410
 Effector memory 217 154 191 132 199 142 .187
 TEMRA 1 4 1 4 1 4 .996
Gut Injury/Leak
 iFABP (pg/mL) 688 916 876 790 841 819 .062
 A1AT (fecal/plasma, N = 261) 1.4 × 10−6 1.7 × 10−6 1.3 × 10−6 1.5 × 10−6 1.3 × 10−6 1.5 × 10−6 .362
 sCD14 (ng/mL) 3553 2996 3432 2931 3467 2967 .476

Abbreviations: A1AT, α-1-antitrypsin; ART, antiretroviral therapy; AUDIT, Alcohol Use Disorder Identification Test; iFABP, intestinal fatty acid-binding protein; HIV, human immunodeficiency virus; IQR, interquartile range; MSM, men who have sex with men; PEth, phosphatidylethanol; sCD14, soluble CD14; TEMRA, terminal effector memory cell re-expressing CD45RA.

aWilcoxon signed-rank or χ 2 test P values where variables were tested for association with sex. Bold indicates P < .050.

bValues beneath the limit of detection (<20 copies/mL) were set to zero.

cUsed in the preceding 4 months.

dValues beneath the limit of detection (<8 ng/μL) were set to zero.